Entia Biosciences, Inc.
ERGO
Rank in Stocks
#34019
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
Share Price
$0.0023
Last synced: 2026-11-12
Market Cap
$64.74K
Change (1 day)
130.00%
Change (1 year)
2,200.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Entia Biosciences, Inc. (ERGO)
Category
Healthcare
EPS for Entia Biosciences, Inc. (ERGO)
EPS as of December 2016 TTM: $-0.05
According to Entia Biosciences, Inc.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2016 the company had an EPS of $-0.05, an increase over its 2015 EPS of $-0.10.
EPS history for Entia Biosciences, Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | 4.80% |
| 2016 | $-0.05 | -47.28% |
| 2015 | $-0.10 | -64.57% |
| 2014 | $-0.28 | -34.88% |
| 2013 | $-0.43 | 104.76% |
| 2012 | $-0.21 | -25.00% |
| 2011 | $-0.28 | 16.67% |
| 2010 | $-0.24 | 71.43% |
| 2009 | $-0.14 | 273.33% |
| 2008 | $-0.04 | 9,275.00% |
| 2007 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -3,325.19% |
US
|
|
| $1.90 | -3,723.66% |
SE
|
|
| $6.83 | -13,143.13% |
FR
|
|
| $0.02 | -137.21% |
HK
|
|
| $2.81 | -5,464.50% |
IT
|
Questions about Entia Biosciences, Inc.'s earnings per share (EPS)
What is Entia Biosciences, Inc.'s earnings per share (EPS)?
Entia Biosciences, Inc.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Dec 2016.
What was Entia Biosciences, Inc.'s earnings per share (EPS) in 2016?
In 2016, Entia Biosciences, Inc.'s earnings per share (EPS) was $-0.05, compared with $-0.10 in 2015.
How has Entia Biosciences, Inc.'s earnings per share (EPS) changed since 2011?
From 2011 to 2016, Entia Biosciences, Inc.'s earnings per share (EPS) was highest in 2016 ($-0.05) and lowest in 2013 ($-0.43).
How does Entia Biosciences, Inc.'s earnings per share (EPS) compare with similar companies?
Entia Biosciences, Inc.'s earnings per share (EPS) ($-0.05) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.